The effects of breast cancer diagnosis and surgery on cognitive functions

Acta Oncologica

Volumn 50, Issue 7, 2011, Pages 1027-1036

  Hedayati, Elham ^a,b   Schedin, Anna ^a   Nyman, Håkan ^a   Alinaghizadeh, Hassan ^a   Albertsson, Maria ^b  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; ATTENTION; BREAST BIOPSY; BREAST CANCER; COGNITION; CONTROLLED STUDY; CYTOLOGY; DEPRESSION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASTECTOMY; MEMORY; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; QUALITY OF LIFE; RADIOGRAPHY;

ADULT; AGED; ATTENTION; BREAST NEOPLASMS; COGNITION; COHORT STUDIES; FEMALE; HUMANS; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; QUALITY OF LIFE; SWEDEN;

EID: 80052899234     PISSN: 0284186X     EISSN: 1651226X     Source Type: Journal    
DOI: 10.3109/0284186X.2011.572911     Document Type: Article

References (36)

1. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007;18:581-92. (Pubitemid 46359643)
2. Shilling V, Jenkins V. Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Eur J Oncol Nurs 2007;11:6-15.
3. Berglund G, Bolund C, Fornander T, Rutqvist LE, Sj öd en PO. Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer 1991;27:1075-81.
4. Wefel JS, Lenzi R, Theriault RL, Davis RN, Meyers CA. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma. Cancer 2004;100:2292-9.
5. Tchen N, Juffs HG, Downie FP, Yi Q-L, Hu H, Chemerynsky I, et al. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 2003;21:4175-83. (Pubitemid 46606186)
6. Wieneke MH, Dienst ER. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology 1995;4:61-6. (Pubitemid 26093776)
7. van Dam FS, Schagen SB, Muller MJ, Boogerd W, vd Wall E, Droogleever Fortuyn ME, et al. Impairment of cognitive function in women receiving adjuvant treatment for high-risk breast cancer: High-dose versus standard-dose chemotherapy. J Natl Cancer Inst 1998;90:210-8. (Pubitemid 28114539)
8. Shilling V, Jenkins V, Morris R, Deutsch G, Bloomfi eld D. The effects of adjuvant chemotherapy on cognition in women with breast cancer - preliminary results of an observational longitudinal study. Breast 2005;14:142-50. (Pubitemid 40353042)
9. Fan HG, Houé dé -Tchen N, Yi QL, Chemerynsky I, Downie FP, Sabate K, et al. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 2005;23:8025-32. (Pubitemid 46657404)
10. Bender CM, Sereika SM, Berga SL, Vogel VG, Brufsky AM, Paraska KK, et al. Cognitive impairment associated with adjuvant therapy in breast cancer. Psycho-Oncology 2006;15: 422-30. (Pubitemid 43826855)
11. Correa DD, Ahles TA. Neurocognitive changes in cancer survivors. Cancer J 2008;14:396-400.
12. Cimprich B, Reuter-Lorenz P, Nelson J, Clark PM, Therrien B, Normolle D, et al. Prechemotherapy alterations in brain function in women with breast cancer. J Clin Exp Neuropsychol 2010;32:324-31.
13. Vardy J, Wefel JS, Ahles T, Tannock IF, Schagen SB. Cancer and cancer-therapy related cognitive dysfunction: An international perspective from the Venice cognitive workshop. Ann Oncol 2008;19:623-9. (Pubitemid 351461030)
14. Hermelink K, Untch M, Lux MP, Kreienberg R, Beck T, Bauerfeind I, et al. Cognitive function during neoadjuvant chemotherapy for breast cancer. Cancer 2007;109: 1905-13.
15. Wefel JS , Lenzi R, Theriault R, Buzdar AU, Cruickshank S, Meyers CA. 'Chemobrain' in breast carcinoma? Cancer 2004; 101:466-75.
16. Newman S, Stygall J, Hirani S, Shaefi S, Maze M. Postoperative cognitive dysfunction after noncardiac surgery: A systematic review. Anesthesiology 2007;106:572-90. (Pubitemid 46662224)
17. Sauér AM, Kalkman C, van Dijk D. Postoperative cognitive decline. J Anesth 2009;23:256-9.
18. Minisini A, Atalay G, Bottomley A, Puglisi F, Piccart M, Biganzoli L. What is the effect of systemic anticancer treatment on cognitive function? Lancet Oncol 2004;5: 273-82. (Pubitemid 38541579)
19. Erlanger DM, Kaushik T, Broshek D, Freeman J, Feldman D, Festa J. Development and validation of a web-based screening tool for monitoring cognitive status. J Head Trauma Rehabil 2002;17:458-76. (Pubitemid 35244785)
20. Erlanger D, Feldman D, Kutner K, Kaushik T, Kroger H, Festa J, et al. Development and validation of a web-based neuropsychological test protocol for sports-related return-toplay decision-making. Arch Clin Neuropsychol 2003;18: 293-316. (Pubitemid 36369368)
21. Beck AT, Steer RA, Brown GK. Manual for beck depression inventory-II. San Antonio: Psychological Corporation; 1996.
22. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: Psychometric properties. J Consult Clin Psychol 1988;56:893-7. (Pubitemid 19008360)
23. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, et al. The European Organization for Research and Treatment of Cancer qlq-c30: A quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-76. (Pubitemid 23073154)
24. Verbeke G, Molenberghs G. Linear mixed models for longitudinal data. New York: Springer-Verlag New York Inc.; 2009.
25. Hedeker D, Gibbons RD. Longitudinal data analysis. New York: John Wiley & Sons Ltd; 2006.
26. Leyland AH, Goldstein H. Multilevel modelling of health statistics. Chichester: John Wiley & Sons Ltd; 2001.
27. Littell RC, Milliken GA, Stroup WW. SAS for mixed models. 2nd ed. New York: SAS Publishing; 2006.
28. Schagen SB, Muller MJ, Boogerd W, Mellenbergh GJ, van Dam FS. Change in cognitive function after chemotherapy: A prospective longitudinal study in breast cancer patients. J Natl Cancer Inst 2006;98:1742-5. (Pubitemid 44942713)
29. Jenkins V, Shilling V, Deutsch G, Bloomfi eld D, Morris R, Allan S, et al. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 2006;94:828-34.
30. Vardy J, Wong K, Yi QL, Park A, Maruff P, Wagner L, et al. Assessing cognitive function in cancer patients. Support Care Cancer 2006;14:1111-8. (Pubitemid 44898793)
31. Gonzalez R, Heaton RK, Moore DJ, Letendre S, Ellis RJ, Wolfson T, et al. Computerized reaction time battery versus a traditional neuropsychological battery: Detecting hivrelated impairments. J Int Neuropsychol Soc 2003;9:64-71. (Pubitemid 36150139)
32. Zehnder AE, Blási S, Berres M, Spiegel R, Monsch AU. Lack of practice effects on neuropsychological tests as early cognitive markers of Alzheimer disease? Am J Alzheimers Dis Other Demen 2007;22:416-26. (Pubitemid 351168890)
33. Quesnel C, Savard J, Ivers H. Cognitive impairments associated with breast cancer treatments: Results from a longitudinal study. Breast Cancer Res Treat 2009;116:113-23.
34. Gurevich M, Devins GM, Rodin GM. Stress response syndromes and cancer: Conceptual and assessment issues. Psychosomatics 2002;43:259-81.
35. Lezak MD. Neuropsychological assessment. 4th ed. New York: Oxford University Press; 2004.
36. Braver TS, Barch DM. A theory of cognitive control, aging cognition, and neuromodulation. Neurosci Biobehav Rev 2002; 26:809-17. (Pubitemid 35430285)